UGT1A1*6 mutation associated with the occurrence and severity in infants with prolonged jaundice

Zhe Yang1, Fen Lin2, Jia-Xin Xu2

  • 1Department of Pediatrics, Chaozhou Central Hospital Affiliated to Southern Medical University, Chaozhou, China.

Frontiers in Pediatrics
|January 6, 2023
PubMed

Insights

The UGT1A1*6 gene variant is a significant risk factor for prolonged jaundice in exclusively breastfed Chinese infants. This genetic factor predicts severe cases of infant jaundice.

Area of Science:

  • Genetics
  • Neonatology
  • Pediatrics

Background:

  • Prolonged jaundice is a common concern in newborns.
  • The UGT1A1 gene plays a crucial role in bilirubin metabolism.
  • Genetic variations may influence jaundice severity in infants.

Purpose of the Study:

  • To investigate the association between UGT1A1 gene variants and prolonged jaundice in Chinese term infants.
  • To determine if UGT1A1*6 influences the occurrence and severity of prolonged jaundice.
  • To identify risk factors for prolonged and severe jaundice in this population.

Main Methods:

  • A retrospective case-control study involving 175 infants with prolonged jaundice and 149 controls.
  • Analysis of UGT1A1 and G6PD gene frequencies and genotypes.
  • Comparison of clinical parameters including feeding mode and jaundice severity (TSB levels).

Main Results:

  • Higher allele and genotype frequencies of UGT1A1*6 were observed in infants with prolonged jaundice compared to controls.
  • UGT1A1*6 was more prevalent in severe jaundice cases than mild-medium cases.
  • Exclusive breastfeeding and UGT1A1*6 (homozygous/heterozygous) were significant risk indicators for prolonged jaundice.

Conclusions:

  • The UGT1A1*6 variant is a risk factor for prolonged jaundice in exclusively breastfed Chinese term infants.
  • UGT1A1*6 is a key predictor of severe prolonged jaundice.
  • Genetic screening for UGT1A1*6 may aid in identifying at-risk infants.
Abstract

Related Concept Videos

Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.1K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
221
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.6K
Genetic Lingo01:11

Genetic Lingo

Overview
103.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K